The critical proportion of immune individuals needed to control hepatitis B

Juan Ospina; Doracelly Hincapié-Palacio

doi:10.1117/12.2222129

13 May 2016 The critical proportion of immune individuals needed to control hepatitis B

Juan Ospina, Doracelly Hincapié-Palacio

Proceedings Volume 9863, Smart Biomedical and Physiological Sensor Technology XIII; 98630T (2016) https://doi.org/10.1117/12.2222129
Event: SPIE Commercial + Scientific Sensing and Imaging, 2016, Baltimore, MD, United States

Abstract

We estimate the critical proportion of immunity (Pc) to control hepatitis B in Medellin - Colombia, based on a random population survey of 2077 individuals of 6-64 years of age. The force of infection (Fi) was estimated according to empirical data of susceptibility by age S(a), assuming a quadratic expression. Parameters were estimated by adjusting data to a nonlinear regression. Fi was defined by -(ds(a)/da)/s(a) and according to the form of the empirical curve S(a) we assume a quadratic expression given by S(a)= Ea2+Ba+C. Then we have the explicit expression for the accumulated Fi by age given by F(a) = -a(Ea+B)/c. The expression of average infection age A is obtained as A = L + EL3/(3C)+BL2/(2C) and the basic reproductive number R₀ is obtained as R₀ = 1 + 6C/(6C+2EL2+3BL). From the las result we obtain the Pc given by Pc= 6C/(12C+2EL2+3BL). Numerical simulations were performed with the age-susceptibility proportion and initial values (a=0.02, b=20, c=100), obtaining an adjusted coefficient of multiple determination of 64.83%. According to the best estimate, the algebraic expressions for S(a) and the Fi were derived. Using the result of Fi, we obtain A = 30, L =85; R0 CI 95%: 1.42 – 1.64 and Pc: 0-0.29. These results indicate that at the worst case, to maintain control of the disease should be immunes at least 30% of susceptible individuals. Similar results were obtained by sex and residential area.

Citation Download Citation

Juan Ospina and Doracelly Hincapié-Palacio "The critical proportion of immune individuals needed to control hepatitis B", Proc. SPIE 9863, Smart Biomedical and Physiological Sensor Technology XIII, 98630T (13 May 2016); https://doi.org/10.1117/12.2222129

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available